Good Quality Cas 32619-42-4 - Camptothecin – Chenlv Detail:
CAS No.:7689-03-4
Latin name: Camptotheca acuminata.Nothapodytes pittosporoide
Part used: nuts /bark
Appearance: light yellow powder
Test method: HPLC
Specification:
Camptothecin98%
Camptothecin99%
Camptothecin is a naturally occurring alkaloid derived from the plant Camptotheca acuminata that was identified in an anticancer drug discovery screen in the 1960s. Camptothecin forms a stable ternary complex, preventing normal DNA re-ligation, and causes the complex to collide with the replication fork, leading to a DNA double-strand break and cytotoxicity.
Camptothecins are mainly used in lung, breast, and brain cancer. However, topotecan is approved by the USFDA for the treatment of lung and ovarian cancer and irinotecan is approved for the treatment of colon cancer.
Product packing: 1kg/bag
Validity period: 2 years
Product detail pictures:
Related Product Guide:
We follow our enterprise spirit of "Quality, Efficiency, Innovation and Integrity". We aim to create much more worth for our buyers with our abundant resources, highly developed machinery, experienced workers and great providers for Good Quality Cas 32619-42-4 - Camptothecin – Chenlv, The product will supply to all over the world, such as: Dominica , Houston , Poland , They're durable modeling and promoting effectively all over the world. Under no circumstances disappearing major functions in a quick time, it's a really should in your case of excellent good quality. Guided by the principle of "Prudence, Efficiency, Union and Innovation. the company make a terrific efforts to expand its international trade, raise its company profit and raise its export scale. We're confident that we've been planning to possess a vibrant prospect and to be distributed all over the world within the years to come.
By Philipppa from Jeddah - 2018.12.11 11:26
The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
By mary rash from Belarus - 2017.11.29 11:09